Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database

H. Inoue (Kagoshima, Japan), K. Milligan (Tokyo, Japan), A. Mcconnon (Dublin, Ireland), H. Yoshisue (Tokyo, Japan), E. Loefroth (Kista, Sweden), M. Mcsharry (Dublin, Ireland), A. Yokoyama (Kochi, Japan), M. Ichinose (Sendai, Japan)

Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session: Asthma treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2552
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Inoue (Kagoshima, Japan), K. Milligan (Tokyo, Japan), A. Mcconnon (Dublin, Ireland), H. Yoshisue (Tokyo, Japan), E. Loefroth (Kista, Sweden), M. Mcsharry (Dublin, Ireland), A. Yokoyama (Kochi, Japan), M. Ichinose (Sendai, Japan). Sub-optimal asthma control with medium- or high-dose ICS/LABA: a retrospective cohort study from Japan claims database. 2552

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA)
Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies
Year: 2019


Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018
Year: 2019



Inhaled corticosteroid/long-acting beta-2 agonist (ICS/LABA) combination can decrease mortality of COPD patients, a nationwide population-based cohort study in Taiwan
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Source: ERJ Open Res, 7 (1) 00778-2020; 10.1183/23120541.00778-2020
Year: 2021



The use of high-dose inhaled corticosteroids and add-on therapy in children in the UK: an observational study of 4332 patients
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Asthma control with inhaled corticosteroid therapy: A real-world observational study
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study
Source: Annual Congress 2009 - Epidemiology of asthma
Year: 2009


High-dose inhaled corticosteroids and add-on therapy use in adults in the UK: an observational study of 22,027 patients
Source: Annual Congress 2004 - Primary care: asthma
Year: 2004


Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses
Source: Eur Respir J 2004; 24: Suppl. 48, 614s
Year: 2004

Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study.
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


Switch from LABA+ICS to a LABA/LAMA combination in symptomatic women with COPD – an analysis of the observational DACCORD study
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Source: Eur Respir J, 53 (4) 1802130; 10.1183/13993003.02130-2018
Year: 2019



Change in asthma management recommendations is associated with reduction of reliever drugs in the real-world setting: a longitudinal retrospective claims data analysis in Burgenland
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020

Asthma control and COPD symptom burden: results from a multi-country observational study (SPRINT) in patients using fixed dose combination (FDC) inhalers
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Unlicensed use of high-dose inhaled corticosteroids in the UK occurs principally with fluticasone - an observational study of 26359 patients
Source: Eur Respir J 2004; 24: Suppl. 48, 501s
Year: 2004

Inhaled corticosteroid therapy and risk of hospitalization with pneumonia: a population-based case-control study from Denmark
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009